BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines...

BioNTech SE American Depositary Share (BNTX) has a valuation score of 32/100 (weak), profitability score of 37/100 (weak), financial health score of 75/100 (strong), Piotroski F-Score of 3/9, Altman Z-Score of 7.19 (safe zone), revenue growth of -45.1% YoY.

Neutral

Analyst Consensus

Strong Buy

Wall Street consensus estimates — not a PMP forecast · Updated Sep 1, 2026

Analyst Recommendations28 analysts · 2026-08-01
6
16
6
Strong Buy 6Buy 16Hold 6Sell 0Strong Sell 0

Recent Market Moves

See all BNTX moves →
DateSessionPriceMoveZ-Score
Aug 28Pre-market$99.00-11.13%-2.48
Aug 19Pre-market$107.11+15.48%10.32
Aug 4Pre-market$89.30-3.20%-2.13
BioNTech SE American Depositary Share (BNTX) Valuation & P/E History →BioNTech SE American Depositary Share (BNTX) Financial Statements →
Share:

Explore More Stocks

AAPLMSFTNVDAGOOGLAMZNMETATSLAJPMWMTVView all stocks →